We opened an office in Nairobi in 1997 that caters to Kenya, Tanzania, Uganda, Rwanda, Sudan, South Sudan, Ethiopia, Burundi, Eritrea and Djibouti. Ranbaxy is a trusted brand amongst doctors in East Africa. Our products enjoy excellent brand equity and we are market leaders for many molecules.
At a Glance
Launched Operations: 1997
No. of Molecules: 40
Leading Molecules: Enhancin (Amoxicillin+Clavulanic Acid), Oframax (Ceftriaxone), Cifran (Ciprofloxacin), Bacqure (Imipenem+Cilastatin), Ranferon (Iron Tonic), Brustan (Ibuprofen+Paracetamol), Revital (Nutritional), Volini (Diclofenac)
Presence in Therapeutic Segments: Anti-infectives, Nutritional, Pain management, Dermatological, Anti-retrovirals (ARVs)
- One of the biggest branded generic companies in East Africa
- Products available in all major hospitals, institutions and retail pharmacies
- Major supplier of Anti-retrovirals (ARVs) to various ministries of health, donor-funded programmes and Non-Governmental Organisations (NGOs)
Area Manager – East Africa
Ranbaxy Laboratories Limited
PO BOX 66180-00800
M02 Mezzanine Floor, Park Place
Plot no 209/20162,
Off Limuru Road,
2nd Avenue Parkland Nairobi–Kenya
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement.
The products listed in this page are meant only of the specific country(ies) mentioned in this page and not for any other market or country.